• 15 years biopharma experience in downstream PD for early/late-stage biotherapeutics • Effective leader building enthusiastic teams to achieve and exceed business goals • Commercial PD for OPDIVO (nivolumab), ORENCIA (abatacept), NULOJIX (belatacept) • Implementation of continuous & intensified manufacturing process, and new technologies • Process characterization for mAbs, fusion proteins, PEGylated proteins, and bispecific mAbs • In-depth understanding of bioseparation and bioprocess engineering principles • Tech transfer to single-use & stainless-steel manufacturing facilities at 500L-40,000L scales • Authoring DS sections for IND & BLA filings, HA briefing reports, and formal responses • Strong problem-solving capabilities, proven record of innovation & scientific publications • Motivated contributor to an organization promoting candor, clarity, and high commitment • Demonstrated interpersonal and managerial skills (>14 years) in driving technical excellence • Authentic leader with a passion to embrace a culture of continuous improvement • Ph.D. in Chem. Eng., specialized in chromatography applications, theories, and modeling
Director, Biologics Downstream Development at Bristol Myers Squibb
Ph.D., Chemical Engineering